Pilot Study: Active Video Gaming to Facilitate Physical Activity and Quality of Life in Kidney Transplant Recipients
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Background:
Renal transplant recipients have a greater risk of morbidity and mortality primarily due to cardiovascular disease when compared to the general population. Cardiovascular disease is responsible for 50% to 60% percent of deaths amongst renal transplant population and death from cardiovascular disease is a leading cause of functioning graft loss.
Physical activity is an effective form of secondary prevention in existing cardiovascular disease reducing all-cause mortality by 25%-30% and has demonstrated positive effects overall on quality of life and well-being. Transplant patients who participated in regular cardiovascular exercise have significant more positive scores on the SF-36 Health Status Questionnaire in comparison to inactive transplant recipients.
Active video gaming is evolving as an innovative method to increase physical activity. Active video gaming has supported physical activity in children and youth. There is however a paucity of literature examining interactive games as a means to facilitate physical activity and its impact on CVD and quality of life in the adult population nor any literature examining AVG and its impact on an adult surgical population.
This pilot study is designed to determine if Active Video Gaming is feasible and is able to lead to behavioral modifications and Quality of Life improvement.
Subject Selection:
This is a pilot study during which 10 patients who have undergone renal transplant will be selected to exercise with Active Video Gaming for a duration of 3 months. The program activity will begin 6 months post surgery.
| Condition | Intervention | Phase |
|---|---|---|
|
Quality of Life |
Behavioral: Workout based on active video gaming |
Phase 1 Phase 2 |
| Study Type: | Interventional |
| Study Design: | Endpoint Classification: Efficacy Study Intervention Model: Single Group Assignment |
| Official Title: | Pilot Study: Active Video Gaming to Facilitate Physical Activity and Quality of Life in Kidney Transplant Recipients |
- Quality of Life [ Time Frame: 3 months post intervention ] [ Designated as safety issue: No ]Quality of life will be measured at baseline and upon completion of the intervention using a standard questionnaire.
| Estimated Enrollment: | 10 |
| Study Start Date: | June 2012 |
| Estimated Study Completion Date: | June 2013 |
| Estimated Primary Completion Date: | June 2013 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Active Video Gaming
An active gaming exercise workout will be provided with QoL measured at baseline and following the 8 week workout schedule. The workout will use the Microsoft Kinect (TM) system with EA Sports Active 2 program.
|
Behavioral: Workout based on active video gaming
A personalized workout regimen will be provided using the Microsoft Kinect Active Gaming Console with EA Sports Active 2 program
Other Names:
|
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Renal transplant patient who want and are able to take part in this study
Exclusion Criteria:
- Cardiac or pulmonary dysfunction diagnosed through preoperative assessment.
- Any surgical complication incurred with transplantation.
- Peripheral vascular disease.
Contacts and Locations| Contact: Ian P Alwayn, MD, PhD | 902-473-6193 | ian.alwayn@cdha.nshealth.ca |
| Canada, Nova Scotia | |
| QEII Health Sciences Center, MOTP | Recruiting |
| Halifax, Nova Scotia, Canada, B3H 2Y9 | |
| Contact: Ian P Alwayn, MD, PhD 902-473-6193 ian.alwayn@cdha.nshealth.ca | |
| Principal Investigator: Ian P Alwayn, MD, PhD | |
| Principal Investigator: | Ian P Alwayn, MD, PhD | CDHA / Dalhousie University |
More Information
No publications provided
| Responsible Party: | Capital District Health Authority, Canada |
| ClinicalTrials.gov Identifier: | NCT01583257 History of Changes |
| Other Study ID Numbers: | CDHA-AVG2012 |
| Study First Received: | April 20, 2012 |
| Last Updated: | July 13, 2012 |
| Health Authority: | Canada: Ethics Review Committee |
ClinicalTrials.gov processed this record on June 18, 2013